Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone ER in persistent pain
NCT00365898Phase 3Terminated
- Sponsor
- Purdue Pharma
- Start
- Jul 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone in chronic pain, sponsored by Purdue Pharma. Started Jul 2005; status: terminated.
02
Drugs
hydromorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00365898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365898.